Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
What Are the Projected Market Size and Growth Rates for the Pharmaceutical Sterility Testing Market From 2025 To 2029?
The size of the pharmaceutical sterility testing market has seen significant expansion in the past few years. It is anticipated to escalate from $1.41 billion in 2024 to $1.54 billion in 2025, reflecting a compound annual growth rate (CAGR) of 9.0%. Factors that have contributed to growth during the historic period encompass an increased demand for high-quality pharmaceutical products, a heightened focus on the safety and effectiveness of drugs, a surge in the demand for biologics and biosimilar drugs, growing occurrence of infectious diseases, and an increase in investments within the realm of life science research.
What Is the Projected Market Size of the Pharmaceutical Sterility Testing Market?
In the coming years, the market size for pharmaceutical sterility testing is projected to experience a swift expansion. With a compound annual growth rate (CAGR) of 20.0%, it is anticipated to reach $3.18 billion by 2029. Factors contributing to the predicted growth during this period include the development of biopharmaceuticals, personalized medicine, an increasing trend towards outsourcing, an emphasis on quality assurance, and preparedness for pandemics. Key trends likely to shape the forecast period are fast microbiological methods, combination products, the importance of data integrity and digitization, automation and robotics, alongside advanced analytical techniques.
Download The Free Sample Report Here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2826&type=smp
Who are the Major Competitors in the Pharmaceutical Sterility Testing Market Outlook?
Major companies operating in the pharmaceutical sterility testing market include Pacific Biolabs Inc., STERIS Corporation, Boston Analytical Inc., Gibraltar Laboratories Inc., Sartorius AG, Solvias AG, SGS S.A., Toxikon Inc., Pace Analytical Services LLC, Charles River Laboratories International Inc., Nelson Laboratories Inc., Rapid Micro Biosystems Inc., bioMérieux Inc., Merck KGaA, WuXi AppTec, Sotera Health LLC, Dynalabs LLC, Infinity Laboratories, Eurofins Scientific SE, Avomeen Analytical Services, Microbac Laboratories Inc., Analytical Lab Group LLC, North American Science Associates Inc., Medical Device Testing Services Inc., Microtest Laboratories Inc., BioScreen Testing Services Inc., Microchem Laboratory Inc., Bactolac Pharmaceutical Inc., Micro Quality Labs Inc., Boston Microfluidics Inc., BioPharma Services Inc., Microbiology Research Associates, BioScience Laboratories Inc.
What Is Fueling Growth in the Pharmaceutical Sterility Testing Market?
The growth in the pharmaceutical sterility testing market can be attributed to the increase in drug launches and a surge in R&D investments. Sterility plays a crucial role in drug manufacturing to prevent product contamination and ensure they are devoid of any viable microorganisms. For instance, Pharmaceutical Technology, an independent US-based source for information, insight, and analysis on bio/pharmaceutical formulation, reported in March 2022 that the UK government committed £260 million ($347 million) to escalate R&D and create innovative treatments, diagnostics, and tools. Similarly, a report by IQVIA, a US-based provider of advanced analytics, technology solutions, and clinical research services in December 2021, predicted that 300 new medicines are expected to be launched over the next five years until 2026. This represents a significant increase over the average number launched over the prior ten years and these drugs are predicted to gear towards specialty, niche, and orphan drugs. The next five years should see new product spending increase by $196 billion, which will be approximately balanced by a $188 billion reduction in brand spending due to loss of exclusivity.
Request For A Customized Report:
https://www.thebusinessresearchcompany.com/customise?id=2826&type=smp
Which Pharmaceutical Sterility Testing Market Segments Are Growing the Fastest?
The pharmaceutical sterility testing market covered in this report is segmented –
1) By Sample: Sterile Drugs, Medical Devices, Biologics and Therapeutics
2) By Product Type: Instruments, Kits and Reagents, Services
3) By Type: In- house, Outsourcing
4) By Test Type: Sterility Testing, Bioburden Testing, Bacterial Endotoxin Testing
5) By End- User: Compounding Pharmacies, Medical Devices Companies, Pharmaceutical Companies
Subsegments:
1) By Sterile Drugs: Injectable Drugs, Infusion Solutions, Ophthalmic Solutions
2) By Medical Devices: Surgical Instruments, Implants, Catheters
3) By Biologics And Therapeutics: Vaccines, Gene Therapies, Cell Therapies
Which Industry Trends Are Shaping the Future of the Pharmaceutical Sterility Testing Market?
Firms within the pharmaceutical testing industry are unveiling innovative pharmaceutical sterility testing products and facilities to diversify their product range and strengthen their market foothold. These companies are bringing to the market advanced solutions and well-furnished services to tap into the burgeoning expansion potential of the pharmaceutical sterility testing market. For example, in June 2022, STEMart, a US-based firm specializing in integrated medical device CRO services, rolled out extensive microbiology and sterility testing for sterile, non-pyrogenic items. Comprehensive microbiology and sterility testing encompass a range of services, including the Antibiotic Potency Test, which assesses the bioactivity or potency of particular antibiotics for medical apparatuses.
Access The Full Report Here:
Which Countries Are Leading the Pharmaceutical Sterility Testing Market?
The countries covered in the pharmaceutical sterility testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.
Purchase The Full Report Today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=2826
This Report Delivers Insight On:
1. How big is the pharmaceutical sterility testing market, and how is it changing globally?
2. Who are the major companies in the pharmaceutical sterility testing market, and how are they performing?
3. What are the key opportunities and risks in the pharmaceutical sterility testing market right now?
4. Which products or customer segments are growing the most in the pharmaceutical sterility testing market?
5. What factors are helping or slowing down the growth of the pharmaceutical sterility testing market?
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 2071930708
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
